Related Experiment Video
Updated: Aug 13, 2026

The Replica Set Method: A High-throughput Approach to Quantitatively Measure Caenorhabditis elegans Lifespan
Published on: June 29, 2018
Abstract:
Becherer and colleagues' report in the European Journal of Radiology of their interesting data on the use of FDG PET in the evaluation of residual masses in seminoma patients is extremely similar to the data that the same authors published in 2004 in the Journal of Clinical Oncology. It would be very helpful to know whether these are the same patients being presented again or a new multicenter study of the same size asking the same question. Oddly, the authors do not acknowledge their prior report even though it was published the same month that the report to the European Journal of Radiology was submitted for review. It would be helpful if the authors explained what the 2005 report adds to the 2004 report for those of us trying to assess the role of FDG PET in this patient population. At this point in time, it appears that there are two studies that have been completed, including a negative trial from the United States and a positive trial (now published three times) from Europe.
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
Censoring Survival Data